|
We asked 50 leaders, Which of the following business challenge poses the greatest
threat to your company?
| Building a sustainable product pipeline |
41% |
| Attracting a skilled workforce |
19% |
| Obtaining/maintaining adequate financing |
11% |
| Regulatory compliance |
29% |
 |
|
|
|
|
|
|
|
6 May, 2014
|
|
|
Pfizer–AstraZeneca: Implications for International Pharma
The Pfizer-AstraZeneca courtship raises many fascinating questions about the future shape of the international pharmaceutical industry. National loyalties have their place in the world, but the history of the drug industry demonstrates that they have only a small role to play in business ...Read more |
Diabetes in China: Is Pharma Listening?
While diabetes is sometimes thought of as a “western” disease, the prevalence is highest in China, which has an estimated 98 million patients with diabetes and has become known as the “diabetes capital of the world.” But diabetes patients in China remain hungry for information about their condition, and are taking to social media to discuss it ... Read more
|
Filling the Digital Skills Gap
Fifty years on from the development of the idea of ‘human capital’, we would readily accept that it is only common sense to invest in developing the skillsets of your staff. But few CEOs are investing in the development of digital skills, writes Peter Houston ... Read more
|
England: Ignore NICE Guidelines at Your Peril
An administrative court has said that a Clinical Commission Group (CCG, a local budget holder for the National Health Service in England) can’t just disagree with guidance from the UK’s National Institute for Health and Clinical Excellence (NICE) — that’s unlawful. This may give a few CCGs pause for thought, writes Leela Barham ... Read more
|
|
|
|
|
